BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32783966)

  • 1. Catalytic Domain Plasticity of MKK7 Reveals Structural Mechanisms of Allosteric Activation and Diverse Targeting Opportunities.
    Schröder M; Tan L; Wang J; Liang Y; Gray NS; Knapp S; Chaikuad A
    Cell Chem Biol; 2020 Oct; 27(10):1285-1295.e4. PubMed ID: 32783966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Covalent Pyrazolopyrimidine-MKK7 Complexes and a Report on a Unique DFG-in/Leu-in Conformation of Mitogen-Activated Protein Kinase Kinase 7 (MKK7).
    Wolle P; Engel J; Smith S; Goebel L; Hennes E; Lategahn J; Rauh D
    J Med Chem; 2019 Jun; 62(11):5541-5546. PubMed ID: 31083997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covalent Docking Identifies a Potent and Selective MKK7 Inhibitor.
    Shraga A; Olshvang E; Davidzohn N; Khoshkenar P; Germain N; Shurrush K; Carvalho S; Avram L; Albeck S; Unger T; Lefker B; Subramanyam C; Hudkins RL; Mitchell A; Shulman Z; Kinoshita T; London N
    Cell Chem Biol; 2019 Jan; 26(1):98-108.e5. PubMed ID: 30449673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the MKK7-JNK (Mitogen-Activated Protein Kinase Kinase 7-c-Jun N-Terminal Kinase) Pathway with Covalent Inhibitors.
    Wolle P; Hardick J; Cronin SJF; Engel J; Baumann M; Lategahn J; Penninger JM; Rauh D
    J Med Chem; 2019 Mar; 62(5):2843-2848. PubMed ID: 30768270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and dynamics of the MKK7-JNK signaling complex.
    Kragelj J; Palencia A; Nanao MH; Maurin D; Bouvignies G; Blackledge M; Jensen MR
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3409-14. PubMed ID: 25737554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the role of MKK7 in excitotoxicity and cerebral ischemia: a novel pharmacological strategy against brain injury.
    Vercelli A; Biggi S; Sclip A; Repetto IE; Cimini S; Falleroni F; Tomasi S; Monti R; Tonna N; Morelli F; Grande V; Stravalaci M; Biasini E; Marin O; Bianco F; di Marino D; Borsello T
    Cell Death Dis; 2015 Aug; 6(8):e1854. PubMed ID: 26270349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity.
    Guo Y; Wang W; Wang J; Feng J; Wang Q; Jin J; Lv M; Li X; Li Y; Ma Y; Shen B; Zhang J
    Hepatology; 2013 Jan; 57(1):140-51. PubMed ID: 22903704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interacting JNK-docking sites in MKK7 promote binding and activation of JNK mitogen-activated protein kinases.
    Ho DT; Bardwell AJ; Grewal S; Iverson C; Bardwell L
    J Biol Chem; 2006 May; 281(19):13169-13179. PubMed ID: 16533805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase 6 promotes growth of glioblastoma through the MKK7/JNK/c-Jun signaling pathway.
    Huang Z; Xia Y; Hu K; Zeng S; Wu L; Liu S; Zhi C; Lai M; Chen D; Xie L; Yuan Z
    J Neurochem; 2020 Jan; 152(2):221-234. PubMed ID: 31390677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the interaction interface of the GADD45β/MKK7 and MKK7/DTP3 complexes by chemical cross-linking mass spectrometry.
    Rega C; Russo R; Focà A; Sandomenico A; Iaccarino E; Raimondo D; Milanetti E; Tornatore L; Franzoso G; Pedone PV; Ruvo M; Chambery A
    Int J Biol Macromol; 2018 Jul; 114():114-123. PubMed ID: 29572137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress-activated kinase pathway alteration is a frequent event in bladder cancer.
    Otto KB; Acharya SS; Robinson VL
    Urol Oncol; 2012; 30(4):415-20. PubMed ID: 22154358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanism of regulation of the atypical protein kinase C by N-terminal domains and an allosteric small compound.
    Zhang H; Neimanis S; Lopez-Garcia LA; Arencibia JM; Amon S; Stroba A; Zeuzem S; Proschak E; Stark H; Bauer AF; Busschots K; Jørgensen TJ; Engel M; Schulze JO; Biondi RM
    Chem Biol; 2014 Jun; 21(6):754-65. PubMed ID: 24836908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for producing selective MAP2K7 inhibitors.
    Murakawa Y; Valter S; Barr H; London N; Kinoshita T
    Bioorg Med Chem Lett; 2020 Nov; 30(22):127546. PubMed ID: 32931911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.
    Simard JR; Getlik M; Grütter C; Pawar V; Wulfert S; Rabiller M; Rauh D
    J Am Chem Soc; 2009 Sep; 131(37):13286-96. PubMed ID: 19572644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse physiological functions of MKK4 and MKK7 during early embryogenesis.
    Asaoka Y; Nishina H
    J Biochem; 2010 Oct; 148(4):393-401. PubMed ID: 20801953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the structural basis of the GADD45beta-mediated inactivation of the JNK kinase, MKK7/JNKK2.
    Papa S; Monti SM; Vitale RM; Bubici C; Jayawardena S; Alvarez K; De Smaele E; Dathan N; Pedone C; Ruvo M; Franzoso G
    J Biol Chem; 2007 Jun; 282(26):19029-41. PubMed ID: 17485467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neddylation controls basal MKK7 kinase activity in breast cancer cells.
    Zhu T; Wang J; Pei Y; Wang Q; Wu Y; Qiu G; Zhang D; Lv M; Li W; Zhang J
    Oncogene; 2016 May; 35(20):2624-33. PubMed ID: 26364603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A crucial role of Cys218 in configuring an unprecedented auto-inhibition form of MAP2K7.
    Sogabe Y; Hashimoto T; Matsumoto T; Kirii Y; Sawa M; Kinoshita T
    Biochem Biophys Res Commun; 2016 Apr; 473(2):476-81. PubMed ID: 26987717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
    Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ
    ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric inhibition of Aurora-A kinase by a synthetic vNAR domain.
    Burgess SG; Oleksy A; Cavazza T; Richards MW; Vernos I; Matthews D; Bayliss R
    Open Biol; 2016 Jul; 6(7):. PubMed ID: 27411893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.